Skip to main content

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 801 Accesses

Abstract

Thyroid dysfunction or deregulation is a clinically significant sequelae of cancer therapy due to the spectrum of physiologic consequences; subsequent thyroid neoplasia is uncommon but potentially serious and raises issues of surveillance strategies. The thyroid gland may be intentionally or incidentally exposed to therapeutic radiation dose in the treatment of many malignancies, such as with prophylactic or therapeutic irradiation of the cervical lymphatics in the treatment of Hodgkin lymphoma and non-Hodgkin lymphoma. Primary hypo- or hyperthyroidism may result from this thyroid gland radiation exposure. Cranio-spinal axis irradiation, as used for some central nervous system (CNS) tumors, may also cause hypo- or hyperthyroidism due to thyroid gland exposure and/or radiation exposure to the hypothalamic-pituitary axis. Additionally, the increased rates of development of both benign nodules and malignant thyroid tumors are a well-documented late effect after cancer therapy. This chapter will focus on the late effects of radiation exposure to the thyroid gland, resulting in increased risks of hyperthyroidism, hypothyroidism, thyroiditis, benign nodule formation, and malignancy [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rubin P, Cassarett G (1968) Clinical radiation pathology. WB Saunders Co. Philadelphia, PA

    Google Scholar 

  2. Hancock SL, McDougall IR, Constine LS (1995) Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 31:1165–1170

    Article  CAS  PubMed  Google Scholar 

  3. Jereczek-Fossa BA, Alterio D, Jassem J et al (2004) Radiotherapy-induced thyroid disorders. Cancer Treat Rev 30:369–384

    Article  CAS  PubMed  Google Scholar 

  4. Fajardo L, Berthrong M, Anderson R (2001) Radiation pathology. Oxford University Press, New York, pp 337–343

    Google Scholar 

  5. Carr RF, LiVolsi VA (1989) Morphologic changes in the thyroid after irradiation for Hodgkin’s and non-Hodgkin’s lymphoma. Cancer 64:825–829

    Article  CAS  PubMed  Google Scholar 

  6. Tronko M, Bogdanova T, Voskoboynyk L et al (2010) Radiation induced thyroid cancer: fundamental and applied aspects. Exp Oncol 32:200–204

    CAS  PubMed  Google Scholar 

  7. Bounacer A, Wicker R, Caillou B et al (1997) High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15:1263–1273

    Article  CAS  PubMed  Google Scholar 

  8. Collins BJ, Chiappetta G, Schneider AB et al (2002) RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 87:3941–3946

    Article  CAS  PubMed  Google Scholar 

  9. Nikiforova MN, Ciampi R, Salvatore G et al (2004) Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett 209:1–6

    Article  CAS  PubMed  Google Scholar 

  10. Ciampi R, Knauf JA, Kerler R et al (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94–101

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Boomsma MJ, Bijl HP, Langendijk JA (2011) Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol 99:1–5

    Article  CAS  PubMed  Google Scholar 

  12. Constine LS, Donaldson SS, McDougall IR et al (1984) Thyroid dysfunction after radiotherapy in children with Hodgkin’s disease. Cancer 53:878–883

    Article  CAS  PubMed  Google Scholar 

  13. Feinmesser R, Lubin E, Segal K et al (1997) Carcinoma of the thyroid in children – a review. J Pediatr Endocrinol Metab 10:561–568

    Article  CAS  PubMed  Google Scholar 

  14. Lazar L, Lebenthal Y, Steinmetz A et al (2009) Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr 154:708–714

    Article  PubMed  Google Scholar 

  15. Tamura K, Shimaoka K, Friedman M (1981) Thyroid abnormalities associated with treatment of malignant lymphoma. Cancer 47:2704–2711

    Article  CAS  PubMed  Google Scholar 

  16. Hancock SL, Cox RS, McDougall IR (1991) Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med 325:599–605

    Article  CAS  PubMed  Google Scholar 

  17. Sklar C, Whitton J, Mertens A et al (2000) Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227–3232

    CAS  PubMed  Google Scholar 

  18. Illes A, Biro E, Miltenyi Z et al (2003) Hypothyroidism and thyroiditis after therapy for Hodgkin’s disease. Acta Haematol 109:11–17

    Article  PubMed  Google Scholar 

  19. Kaplan MM, Garnick MB, Gelber R et al (1983) Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med 74:272–280

    Article  CAS  PubMed  Google Scholar 

  20. Bolling T, Geisenheiser A, Pape H et al (2011) Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the “Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence” (RiSK). Int J Radiat Oncol Biol Phys 81:e787–e791

    Article  PubMed  Google Scholar 

  21. Demirkaya M, Sevinir B, Saglam H et al (2011) Thyroid functions in long-term survivors of pediatric Hodgkin’s lymphoma treated with chemotherapy and radiotherapy. J Clin Res Pediatr Endocrinol 3:89–94

    Article  PubMed Central  PubMed  Google Scholar 

  22. Chow EJ, Friedman DL, Stovall M et al (2009) Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 53:432–437

    Article  PubMed Central  PubMed  Google Scholar 

  23. Devney RB, Sklar CA, Nesbit ME Jr et al (1984) Serial thyroid function measurements in children with Hodgkin disease. J Pediatr 105:223–227

    Article  CAS  PubMed  Google Scholar 

  24. Sutcliffe SB, Chapman R, Wrigley PF (1981) Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin’s disease. Med Pediatr Oncol 9:439–448

    Article  CAS  PubMed  Google Scholar 

  25. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR (1991) Thyroid function after treatment of brain tumors in children. J Pediatr 119:733–737

    Article  CAS  PubMed  Google Scholar 

  26. Sklar CA, Kim TH, Ramsay NK (1982) Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 73:688–694

    Article  CAS  PubMed  Google Scholar 

  27. Borgstrom B, Bolme P (1994) Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 13:59–64

    CAS  PubMed  Google Scholar 

  28. Boulad F, Bromley M, Black P et al (1995) Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 15:71–76

    CAS  PubMed  Google Scholar 

  29. Hawkins MM, Kingston JE (1988) Malignant thyroid tumours following childhood cancer. Lancet 2:804

    Article  CAS  PubMed  Google Scholar 

  30. Socie G, Salooja N, Cohen A et al (2003) Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101:3373–3385

    Article  CAS  PubMed  Google Scholar 

  31. Sanders JE, Hoffmeister PA, Woolfrey AE et al (2009) Thyroid function following hematopoietic cell transplantation in children: 30 years’ experience. Blood 113:306–308

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S (1988) Solitary thyroid nodule: diagnosis and management. Med Clin N Am 72:1177–1211

    CAS  PubMed  Google Scholar 

  33. Acharya S, Sarafoglou K, LaQuaglia M et al (2003) Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 97:2397–2403

    Article  PubMed  Google Scholar 

  34. Metzger ML, Howard SC, Hudson MM et al (2006) Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr Blood Cancer 46:314–319

    Article  PubMed  Google Scholar 

  35. Bhatia S, Yasui Y, Robison LL et al (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol 21:4386–4394

    Article  PubMed  Google Scholar 

  36. Tucker MA, Jones PH, Boice JD Jr et al (1991) Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 51:2885–2888

    CAS  PubMed  Google Scholar 

  37. Metayer C, Lynch CF, Clarke EA et al (2000) Second cancers among long-term survivors of Hodgkin’s disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435–2443

    CAS  PubMed  Google Scholar 

  38. Neglia JP, Friedman DL, Yasui Y et al (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93:618–629

    Article  CAS  PubMed  Google Scholar 

  39. Sankila R, Garwicz S, Olsen JH et al (1996) Risk of subsequent malignant neoplasms among 1,641 Hodgkin’s disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol 14:1442–1446

    CAS  PubMed  Google Scholar 

  40. Svahn-Tapper G, Garwicz S, Anderson H et al (2006) Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries. Acta Oncol 45:438–448

    Article  PubMed  Google Scholar 

  41. Wolden SL, Lamborn KR, Cleary SF et al (1998) Second cancers following pediatric Hodgkin’s disease. J Clin Oncol 16:536–544

    CAS  PubMed  Google Scholar 

  42. Taylor AJ, Croft AP, Palace AM et al (2009) Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer 125:2400–2405

    Article  CAS  PubMed  Google Scholar 

  43. Schneider AB, Recant W, Pinsky SM et al (1986) Radiation-induced thyroid carcinoma. Clinical course and results of therapy in 296 patients. Ann Intern Med 105:405–412

    Article  CAS  PubMed  Google Scholar 

  44. Adams MJ, Shore RE, Dozier A et al (2010) Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort. Radiat Res 174:753–762

    Article  CAS  PubMed  Google Scholar 

  45. Favus MJ, Schneider AB, Stachura ME et al (1976) Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1,056 patients. N Engl J Med 294:1019–1025

    Article  CAS  PubMed  Google Scholar 

  46. Ron E, Lubin JH, Shore RE et al (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259–277

    Article  CAS  PubMed  Google Scholar 

  47. DeGroot LJ (1989) Clinical review 2: diagnostic approach and management of patients exposed to irradiation to the thyroid. J Clin Endocrinol Metab 69:925–928

    Article  CAS  PubMed  Google Scholar 

  48. McDougall IR, Coleman CN, Burke JS et al (1980) Thyroid carcinoma after high-dose external radiotherapy for Hodgkin’s disease: report of three cases. Cancer 45:2056–2060

    Article  CAS  PubMed  Google Scholar 

  49. Garwicz S, Anderson H, Olsen JH et al (2000) Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer 88:672–678

    Article  CAS  PubMed  Google Scholar 

  50. Sandhu A, Constine LS, O’Mara RE et al (2000) Subclinical thyroid disease after radiation therapy detected by radionuclide scanning. Int J Radiat Oncol Biol Phys 48:181–188

    Article  CAS  PubMed  Google Scholar 

  51. Rose J, Wertheim BC, Guerrero MA (2012) Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy. Am J Surg 204:881–886; discussion 886–887

    Article  PubMed  Google Scholar 

  52. Bhatti P, Veiga LH, Ronckers CM et al (2010) Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 174:741–752

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Haddy N, El-Fayech C, Guibout C et al (2012) Thyroid adenomas after solid cancer in childhood. Int J Radiat Oncol Biol Phys 84:e209–e215

    Article  PubMed  Google Scholar 

  54. Sigurdson AJ, Ronckers CM, Mertens AC et al (2005) Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 365:2014–2023

    Article  PubMed  Google Scholar 

  55. Veiga LH, Bhatti P, Ronckers CM et al (2012) Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 21:92–101

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Bhatia S, Ramsay NK, Bantle JP et al (1996) Thyroid abnormalities after therapy for Hodgkin’s disease in childhood. Oncologist 1:62–67

    PubMed  Google Scholar 

  57. Liao Z, Ha CS, Vlachaki MT et al (2001) Mantle irradiation alone for pathologic stage I and II Hodgkin’s disease: long-term follow-up and patterns of failure. Int J Radiat Oncol Biol Phys 50:971–977

    Article  CAS  PubMed  Google Scholar 

  58. Constine LS, Tarbell N, Hudson MM et al (2008) Subsequent malignancies in children treated for Hodgkin’s disease: association with gender and radiation dose. Int J Radiat Oncol Biol Phys 72:24–33

    Article  PubMed Central  PubMed  Google Scholar 

  59. Dores GM, Metayer C, Curtis RE et al (2002) Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years. J Clin Oncol 20:3484–3494

    Article  PubMed  Google Scholar 

  60. Green DM, Hyland A, Barcos MP et al (2000) Second malignant neoplasms after treatment for Hodgkin’s disease in childhood or adolescence. J Clin Oncol 18:1492–1499

    CAS  PubMed  Google Scholar 

  61. Ronckers CM, Sigurdson AJ, Stovall M et al (2006) Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers. Radiat Res 166:618–628

    Article  CAS  PubMed  Google Scholar 

  62. Faraci M, Barra S, Cohen A et al (2005) Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 63:1568–1575

    Article  PubMed  Google Scholar 

  63. Bucci A, Shore-Freedman E, Gierlowski T et al (2001) Behavior of small thyroid cancers found by screening radiation-exposed individuals. J Clin Endocrinol Metab 86:3711–3716

    Article  CAS  PubMed  Google Scholar 

  64. Getaz EP, Shimaoka K, Rao U (1979) Anaplastic carcinoma of the thyroid following external irradiation. Cancer 43:2248–2253

    Article  CAS  PubMed  Google Scholar 

  65. Komorowski RA, Hanson GA, Garancis JC (1978) Anaplastic thyroid carcinoma following low-dose irradiation. Am J Clin Pathol 70:303–307

    CAS  PubMed  Google Scholar 

  66. Wiest PW, Hartshorne MF, Inskip PD et al (1998) Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med 17:487–496

    CAS  PubMed  Google Scholar 

  67. Eden K, Mahon S, Helfand M (2001) Screening high-risk populations for thyroid cancer. Med Pediatr Oncol 36:583–591

    Article  CAS  PubMed  Google Scholar 

  68. Cappelli C, Castellano M, Pirola I et al (2007) The predictive value of ultrasound findings in the management of thyroid nodules. QJM 100:29–35

    Article  CAS  PubMed  Google Scholar 

  69. Stewart RR, David CL, Eftekhari F et al (1989) Thyroid gland: US in patients with Hodgkin disease treated with radiation therapy in childhood. Radiology 172:159–163

    Article  CAS  PubMed  Google Scholar 

  70. Soberman N, Leonidas JC, Cherrick I et al (1991) Sonographic abnormalities of the thyroid gland in longterm survivors of Hodgkin disease. Pediatr Radiol 21:250–253

    Article  CAS  PubMed  Google Scholar 

  71. Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  PubMed  Google Scholar 

  72. Gharib H, Papini E, Valcavi R et al (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63–102

    Article  PubMed  Google Scholar 

  73. Marcial-Vega VA, Order SE, Lastner G et al (1990) Prevention of hypothyroidism related to mantle irradiation for Hodgkin’s disease: preparative phantom study. Int J Radiat Oncol Biol Phys 18:613–618

    Article  CAS  PubMed  Google Scholar 

  74. Bantle JP, Lee CK, Levitt SH (1985) Thyroxine administration during radiation therapy to the neck does not prevent subsequent thyroid dysfunction. Int J Radiat Oncol Biol Phys 11:1999–2002

    Article  CAS  PubMed  Google Scholar 

  75. Common late effects of childhood cancer by body system: thyroid gland (2008) Last accessed 30 June 2008. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/lateeffects/HealthProfessional/page3#Section_67

  76. Sklar CA, Constine LS (1995) Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31:1113–1121

    Article  CAS  PubMed  Google Scholar 

  77. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules (2006) Endocr Pract 12:63–102

    Google Scholar 

  78. Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142

    Article  PubMed  Google Scholar 

  79. Mihailescu DV, Schneider AB (2008) Size, number and distribution of thyroid nodules and their risk of malignancy in radiation-exposed patients who underwent surgery. J Clin Endocrinol Metab. 93(6):2188–93

    Google Scholar 

  80. Samaan NA, Schultz PN, Ordonez NG et al (2008) A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood. J Clin Endocrinol Metab 93(6):2188–2193

    Article  Google Scholar 

  81. Tillman BN, Elbermani W (2007) eds. Atlas of human anatomy, clinical edition, 1st edn. Mud Puddle Books, Inc. New York

    Google Scholar 

  82. Zhang S (1999) An atlas of histology, Springer, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael T. Milano .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing

About this chapter

Cite this chapter

Milano, M.T., Dhakal, S., Schwartz, C.L., Constine, L.S. (2015). The Thyroid Gland. In: Schwartz, C., Hobbie, W., Constine, L., Ruccione, K. (eds) Survivors of Childhood and Adolescent Cancer. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-16435-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16435-9_9

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16434-2

  • Online ISBN: 978-3-319-16435-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics